MGI

MGI Tech Co., Ltd. (referred to as MGI) adheres to the concept of "Innovative Manufacturing Leading Life Science and Technology" and is committed to becoming a creator of core tools in life science and technology. Focusing on the fields of life science and biotechnology, MGI's main business involves the research, production, and sales of related products such as instruments, reagents, and consumables, providing real-time, panoramic, and whole-lifecycle digital life equipment and systems for industries like precision medicine, precision agriculture, and precision health. MGI was founded in 2016. As of December 31, 2023, MGI has 2,860 employees, with approximately 33.4% being R&D personnel. Its business operations span more than 100 countries and regions across six continents, serving over 2,800 cumulative global users. It has established research, production bases, training, and after-sales service centers in multiple countries and regions around the world. MGI has become one of the few companies globally capable of independently developing and mass-producing clinical-grade genetic sequencers with different throughputs ranging from Gb-level to Tb-level.